Stanford Center For Law And The Biosciences Podcast Series

Hank Greely, Amanda Rubin, Roland Nadler, and Jake Sherkow discuss the brain map initiative, transcranial direct current stimulation, the Amgen v. Retirement Plan case, and mice with human neurons.

Shubha Ghosh from the University of Wisconsin discusses his recent work with Hank Greely.

Andrew Torrance from the University of Kansas discusses his recent work with Hank Greely.

Hear Mark Lemley's oral argument in the FTC v. Actavis case.

Nita Farahany from Duke discusses her recent work with Hank Greely.

Alta Charo from the University of Wisconsin discusses her recent work with Hank Greely.

Carl Elliot from the University of Minnesota discusses his recent work with Hank Greely.

Susan M. Wolf from the University of Minnesota discusses her recent work with Hank Greely.

Patrick Lin from Cal Poly San Luis Obispo discusses his recent work with Hank Greely.

Alex Capron from USC discusses his recent work with Hank Greely.

Andrea Roth from UC Berkeley discusses her recent work with Hank Greely.

Hank Greely, Jake Sherkow, and Matt Lamkin discuss race issues in genetic testing, the myth of anonymity in genetic donation, and the prospects for "bringing back" the Neanderthal.

Robert Merges from UC Berkeley discusses his recent work with Hank Greely.

Peter Lee from UC Davis discusses his recent work with Hank Greely.

Hank Greely, Jake Sherkow, and Matt Lamkin discuss the Supreme Court cases Bowman v. Monsanto, Mutual Pharmaceutical v. Bartlett, FTC v. Watson, Maryland v. King, and Association for Molecular Pathology v. Myriad.

Hank Greely and fellows discuss the In re Frito Lay and U.S. v. Carolina cases and recent developments in genetic testing.

Hank Greely, Jake Sherkow, and Matt Lamkin discuss DNA collection statutes, children with three parents, gene therapy for clinical use, and how the biosciences are implicated in the election.

Hank Greely and Jake Sherkow discuss mouse eggs and cloning, recent Nobel Prize winners, the fungal meningitis outbreak, bioscience fiction, and exoplanets.

Hank Greely, Jake Sherkow, and Matt Lamkin discuss fMRI lie-detection services, pay-to-delay settlements between branded pharmaceutical and generics companies, and the arguments against increased regulation of enhancement technologies.

Hank Greely and Matt Lamkin, in the inaugural podcast discuss the tension between promoting healthy behaviours and obtaining informed consent, recent developments in forensic DNA, and an upcoming conference at Stanford about prenatal genetic testing.